Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting
-
Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting
-
AGF Investments Announces April 2024 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF
-
Vishay Intertechnology Board of Directors Issues Statement in Response to Open Letter Submitted by Mountaineer Partners Management
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Man Group PLC : Form 8.3 - International Paper Company
-
Dime Community Bancshares, Inc. Reports First Quarter 2024 Results With Earnings Per Share Increasing By 11% Versus the Prior Quarter
-
ClimateAi Launches AI-Driven Crop Yield Outlook Amid Global Climate Volatility
-
Dimensional Fund Advisors Ltd. : Form 8.3 - WINCANTON PLC - Ordinary Shares
-
Man Group PLC : Form 8.3 - Quanex Building Products Corporation
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
-
Man Group PLC : Form 8.3 - Tyman plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - QUANEX BUILDING PRODUCTS - Ordinary Shares
-
Hitachi Energy to invest additional $1.5 billion to ramp up global transformer production by 2027
-
CorVel Announces New Integrations for Managed Care Services Enabling Partners to Increase Connectivity and Create a Seamless Workflow Experience
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Infinite Reality Acquires the Drone Racing League for $250 Million, Solidifying Position as Global Leader in Immersive Technology & Experiences
-
Infinite Reality Acquires the Drone Racing League for $250 Million, Solidifying Position as Global Leader in Immersive Technology & Experiences
-
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2024
-
Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024
-
AIP Realty Trust Announces Units for Debt Issuance
-
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
-
Compelling Coarse Ore Flotation Results Indicate Throughput Upside for Kharmagtai
-
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
-
Sandy Spring Bancorp Reports First Quarter Earnings of $20.4 Million
-
First Commonwealth Announces First Quarter 2024 Earnings; Increases Quarterly Dividend
-
The City of Toronto Commits to Secure Placements for CDI College Practicum Students
-
CBDistillery™ shhh+ Distilled Deep Sleep Gummies Deliver Better Sleep, Improved Quality of Life
-
Lithium Ionic Expands Newly Discovered Zone at Salinas; Drills 1.53% Li2O over 15m, incl. 2.31% Li2O over 8m; 1.15% Li2O over 19m, incl. 1.67% Li2O over 10m, and 1.32% Li2O over 14m
-
AI Networking Innovator Nile Expands its Executive Team, Adding Industry Veteran Bill Choi as CFO
-
Mobilicom Launches Groundbreaking OS3 Operations System World’s First for the Drones & Robotics Industry
-
Skye Bioscience to Present at Upcoming Investment Conferences
-
Solaris Reports First Drilling Results from 2024 Program and Exploration Update, Including 150m of 0.67% CuEq within 384m of 0.51% CuEq and 284m of 0.53% CuEq from Near Surface
-
Mobilicom Launches Groundbreaking OS3 Operations System World’s First for the Drones & Robotics Industry
-
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
-
Regeneration Biomedical Doses First Patient in a First-in-Human Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brain of Patients with Alzheimer’s Disease
-
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
-
Plug Continues to Make Substantial Advancement in Hydrogen Generation Buildout
-
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma
-
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024
-
GXO Renews Agreement with Mars
-
Gen II Expands Presence in the Southeastern United States with New Florida Office
-
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
